Digoxin withdrawal worsens clinical status in stable patients with heart failure receiving optimal contemporaneous therapy--a randomized controlled trial

Affiliations

• ¹ Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia; Clinical Pharmacology Department, Alfred Health, Melbourne, Australia. Electronic address: ingrid.hopper@monash.edu.
• ² Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia; Clinical Pharmacology Department, Alfred Health, Melbourne, Australia.
• ³ Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia; Department of Cardiology B, Oslo University Hospital, Oslo, Norway.
• ⁴ Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia; Department of Cardiology, Tokyo Medical University, Tokyo, Japan.
• ⁵ Clinical Pharmacology Department, Alfred Health, Melbourne, Australia.
• ⁶ Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.